Biomarkers of Ovarian Cancer

Although 6% of all cancer death in women is caused by ovarian cancer, there has been relatively little improvement in survival rates over the past decade. While disease outcome is significantly higher with early diagnosis, currently there is no noninvasive method to accurately detect early stage ovarian cancer. This presentation will focus on circulating biomarkers that have the potential to detect and predict outcome in ovarian cancer.

Video Comments

Log in to post a comment about this video.

Video Options

    • Add to Bookmarks